Tags

Type your tag names separated by a space and hit enter

[Progressive moderate mitral regurgitation in a children with Axenfeld-Rieger syndrome. The importance of cardiologic follow up].
Arch Argent Pediatr. 2016 Dec 01; 114(6):e417-e420.AA

Abstract

Axenfeld-Rieger syndrome is a congenital disease with an estimated prevalence of one in 200,000 individuals. This is an ophthalmic disorder related to anterior segment dysgenesis, which may be present from the neonatal period. It is associated with extraocular affectations such as cranial dimorphism, maxillofacial or dental anomalies. Cardiological or pituitary manifestations are less common. The congenital heart disease in Axenfeld-Rieger syndrome has been described in very few cases in the literature. We report a 7-year-old patient with Axenfeld-Rieger syndrome and mild mitral insufficiency since the age of 3 years, which is progressing to moderate mitral regurgitation at the present time. The cardiologic follow up may be indicated in patients with Axenfeld-Rieger syndrome.

Authors+Show Affiliations

Unidad de Cardiología Pediátrica, Servicio de Pediatría, Hospital Universitario de San Juan de Alicante, Alicante, España. pacosanchezferrer0@hotmail.com.Instituto de Bioingeniería y Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Universidad Miguel Hernández, Alicante, España.

Pub Type(s)

Case Reports
Journal Article

Language

spa

PubMed ID

27869423

Citation

Sánchez Ferrer, Francisco, and María D. Grima Murcia. "[Progressive Moderate Mitral Regurgitation in a Children With Axenfeld-Rieger Syndrome. the Importance of Cardiologic Follow Up]." Archivos Argentinos De Pediatria, vol. 114, no. 6, 2016, pp. e417-e420.
Sánchez Ferrer F, Grima Murcia MD. [Progressive moderate mitral regurgitation in a children with Axenfeld-Rieger syndrome. The importance of cardiologic follow up]. Arch Argent Pediatr. 2016;114(6):e417-e420.
Sánchez Ferrer, F., & Grima Murcia, M. D. (2016). [Progressive moderate mitral regurgitation in a children with Axenfeld-Rieger syndrome. The importance of cardiologic follow up]. Archivos Argentinos De Pediatria, 114(6), e417-e420. https://doi.org/10.5546/aap.2016.e417
Sánchez Ferrer F, Grima Murcia MD. [Progressive Moderate Mitral Regurgitation in a Children With Axenfeld-Rieger Syndrome. the Importance of Cardiologic Follow Up]. Arch Argent Pediatr. 2016 Dec 1;114(6):e417-e420. PubMed PMID: 27869423.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Progressive moderate mitral regurgitation in a children with Axenfeld-Rieger syndrome. The importance of cardiologic follow up]. AU - Sánchez Ferrer,Francisco, AU - Grima Murcia,María D, PY - 2016/02/12/received PY - 2016/05/11/accepted PY - 2016/11/22/entrez PY - 2016/11/22/pubmed PY - 2018/1/30/medline KW - Axenfeld-Rieger syndrome KW - Heart diseases KW - Interdisciplinary health team KW - Mitral regurgitation SP - e417 EP - e420 JF - Archivos argentinos de pediatria JO - Arch Argent Pediatr VL - 114 IS - 6 N2 - Axenfeld-Rieger syndrome is a congenital disease with an estimated prevalence of one in 200,000 individuals. This is an ophthalmic disorder related to anterior segment dysgenesis, which may be present from the neonatal period. It is associated with extraocular affectations such as cranial dimorphism, maxillofacial or dental anomalies. Cardiological or pituitary manifestations are less common. The congenital heart disease in Axenfeld-Rieger syndrome has been described in very few cases in the literature. We report a 7-year-old patient with Axenfeld-Rieger syndrome and mild mitral insufficiency since the age of 3 years, which is progressing to moderate mitral regurgitation at the present time. The cardiologic follow up may be indicated in patients with Axenfeld-Rieger syndrome. SN - 1668-3501 UR - https://www.unboundmedicine.com/medline/citation/27869423/[Progressive_moderate_mitral_regurgitation_in_a_children_with_Axenfeld_Rieger_syndrome__The_importance_of_cardiologic_follow_up]_ L2 - https://doi.org/10.5546/aap.2016.e417 DB - PRIME DP - Unbound Medicine ER -